NASDAQ:BCPCBalchem Stock Price, Forecast & News

Balchem's stock was trading at $89.29 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BCPC shares have increased by 4.3% and is now trading at $93.15. View which stocks have been most impacted by Coronavirus.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Balchem.

Balchem is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Balchem.

Balchem Co. (NASDAQ:BCPC) released its quarterly earnings results on Friday, May, 1st. The basic materials company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.22. The basic materials company earned $174.44 million during the quarter, compared to analysts' expectations of $169.87 million. Balchem had a return on equity of 14.30% and a net margin of 12.20%. Balchem's quarterly revenue was up 11.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.73 EPS. View Balchem's earnings history.

Balchem announced an annual dividend on Wednesday, December 18th. Investors of record on Monday, December 30th will be given a dividend of $0.52 per share on Friday, January 17th. This represents a yield of 0.51%. The ex-dividend date of this dividend is Friday, December 27th. This is a boost from Balchem's previous annual dividend of $0.47. View Balchem's dividend history.

1 Wall Street analysts have issued 12-month target prices for Balchem's shares. Their forecasts range from $104.00 to $104.00. On average, they expect Balchem's stock price to reach $104.00 in the next twelve months. This suggests a possible upside of 11.6% from the stock's current price. View analysts' price targets for Balchem.

News coverage about BCPC stock has been trending negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Balchem earned a daily sentiment score of -2.1 on InfoTrie's scale. They also assigned media headlines about the basic materials company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news about Balchem.

Balchem saw a decrease in short interest during the month of June. As of June 30th, there was short interest totaling 493,100 shares, a decrease of 8.7% from the June 15th total of 540,000 shares. Based on an average daily volume of 173,600 shares, the days-to-cover ratio is presently 2.8 days. Currently, 1.5% of the shares of the stock are sold short. View Balchem's Current Options Chain.

Some companies that are related to Balchem include Ecolab (ECL), Sherwin-Williams (SHW), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), Albemarle (ALB), NewMarket (NEU), Ashland Global (ASH), W. R. Grace & Co (GRA), Quaker Chemical (KWR), PolyOne (POL), HB Fuller (FUL), Sensient Technologies (SXT), Stepan (SCL) and Innospec (IOSP). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Gilead Sciences (GILD), AbbVie (ABBV), CVS Health (CVS), Ecolab (ECL), Adobe (ADBE), Mastercard (MA), Altria Group (MO), NVIDIA (NVDA), Pfizer (PFE) and Starbucks (SBUX).

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

Balchem's stock is owned by a number of institutional and retail investors. Top institutional investors include Bath Savings Trust Co (0.16%) and State of Alaska Department of Revenue (0.09%). Company insiders that own Balchem stock include Daniel E Knutson, David F Ludwig and Scott C Mason. View institutional ownership trends for Balchem.

BCPC stock was sold by a variety of institutional investors in the last quarter, including Bath Savings Trust Co. View insider buying and selling activity for Balchem.

BCPC stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have bought Balchem stock in the last two years include Daniel E Knutson, and Scott C Mason. View insider buying and selling activity for Balchem.

Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BCPC stock can currently be purchased for approximately $93.15.

Balchem has a market capitalization of $3.01 billion and generates $643.71 million in revenue each year. The basic materials company earns $79.67 million in net income (profit) each year or $3.19 on an earnings per share basis. Balchem employs 1,424 workers across the globe.

The official website for Balchem is www.balchem.com.

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at 845-326-5600 or via email at [email protected]